Result and key figures

2025 was a year of strong international growth and significant new openings for Mehiläinen. The company expanded into three new countries, while continuing profitable growth across all business areas.

Mehiläinen’s revenue for 2025 increased by 16.9% from the previous year to EUR 2,413.2 (2,063.5) million. Growth was strong in all operating countries and across different business areas. In the first half of the year, Mehiläinen expanded into Lithuania with the acquisition of InMedica Group, and by the end of the year, acquisitions were concluded for healthcare companies Regina Maria in Romania and MediGroup in Serbia.

– During 2025, Mehiläinen became a truly international group and established its position as one of Europe's leading providers of integrated outpatient healthcare services. By the end of the year, we had 55,000 professionals in seven countries. I am also proud of the increased personnel ownership, which demonstrates the commitment to the firm and its entrepreneurial spirit, says Janne-Olli Järvenpää, CEO of Mehiläinen Group.

Mehiläinen’s underlying EBITA2) was EUR 339.4 (289.1) million, and the financial result for the year was EUR 88.5 (39.2) million, or approximately 3.7% of revenue. During the year, Mehiläinen made significant investments in expanding its service network in the fields of gynaecology, therapy services, dental health, and orthopaedics in multiple countries. In Finland, home care services and residential care services for the elderly grew organically and through acquisitions.

Investments in facilities, digital development, medical devices, and other fixed assets grew by about 53% from the previous year to EUR 106.8 (69.8) million. Investments, including acquisitions, increased to EUR 1,125.3 (192.3) million.

Mehiläinen’s tax footprint increased to EUR 544.4 (446.9) million during the year. Corporate income taxes amounted to EUR 23.1 (33.1) million.